| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Integrin-linked protein kinase |
|---|
| Ligand | BDBM123963 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro Ezyme Assay |
|---|
| Temperature | 313.15±n/a K |
|---|
| IC50 | 200±n/a nM |
|---|
| Comments | extracted |
|---|
| Citation |  Zhang, Z; Daynard, TS; Wang, S; Du, X; Chopiuk, GB; Yan, J; Chen, J; Sviridov, SV Pyrazolylbenzothiazole derivatives and their use as therapeutic agents US Patent US8754233 Publication Date 6/17/2014 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Integrin-linked protein kinase |
|---|
| Name: | Integrin-linked protein kinase |
|---|
| Synonyms: | ILK | ILK1 | ILK2 | ILK_HUMAN | Integrin-linked protein kinase (ILK) | Serine/threonine-protein kinase ILK-1 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 51429.75 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q13418 |
|---|
| Residue: | 452 |
|---|
| Sequence: | MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARI
NVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLV
ANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIPYKDTFWKGTTRTRPRNG
TLNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECP
RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD
MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQCPGRMYAPAWVAPEA
LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH
VCKLMKICMNEDPAKRPKFDMIVPILEKMQDK
|
|
|
|---|
| BDBM123963 |
|---|
| n/a |
|---|
| Name | BDBM123963 |
|---|
| Synonyms: | US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-benzothiazole-6-sulfonic acid [2-(3H-imidazol-4-yl)-ethyl]-amide |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H17N7O2S2 |
|---|
| Mol. Mass. | 403.482 |
|---|
| SMILES | Cc1[nH]nc(N)c1-c1nc2ccc(cc2s1)S(=O)(=O)NCCc1cnc[nH]1 |
|---|
| Structure | 
|
|---|
Search and Browse
